For the 2nd consecutive year, the challenges raised by the COVID-19 outbreak were the main drivers for ECRIN’s new activities in 2021. The year also marks the launch of the ECRIN ‘strategic plan 2021-2023‘.
Read this report to learn how ECRIN established a new corporate identity, engaged in a strategic partnership with EUPATI, presented EU-AMRI, continued providing high-quality services to its clinical trials portfolio, and contributed to many projects on health research, data sharing and reuse.
You can read all about this, and more, in the 2021 Annual Report or you can click on the links and listen to some of the interviews that are included with different stakeholders.
The annual report is now available through the ECRIN website.
